Evidence map›Paper›PMID 38267425›Full record

ArticleNature communications2024

Rational strain design with minimal phenotype perturbation.

Bharath Narayanan, Daniel Weilandt, Maria Masid, Ljubisa Miskovic, Vassily Hatzimanikatis

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advances in Machine Learning Models for Predicting Enzyme Kinetic Parameters.Journal of chemical information and modeling · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Bharath NarayananLaboratory of Computational Systems Biology (LCSB), Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015, Lausanne, Switzerland.
Daniel WeilandtLaboratory of Computational Systems Biology (LCSB), Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015, Lausanne, Switzerland.
Maria MasidLudwig Institute for Cancer Research, Department of Oncology, University of Lausanne, and Lausanne University Hospital (CHUV), Lausanne, Switzerland.ORCID 0000-0001-6470-5083
Ljubisa MiskovicLaboratory of Computational Systems Biology (LCSB), Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015, Lausanne, Switzerland. ljubisa.miskovic@epfl.ch.ORCID 0000-0001-7333-8211
Vassily HatzimanikatisLaboratory of Computational Systems Biology (LCSB), Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015, Lausanne, Switzerland. vassily.hatzimanikatis@epfl.ch.ORCID 0000-0001-6432-4694
École Polytechnique Fédérale de Lausanne · CHLudwig Cancer Research · CHPrinceton University · USUniversity of Cambridge · GB

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 814408Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) CRSII5_198543Vetenskapsrådet (Swedish Research Council) 2016-06160
6 · The paper itself

Abstract

Devising genetic interventions for desired cellular phenotypes remains challenging regarding time and resources. Kinetic models can accelerate this task by simulating metabolic responses to genetic perturbations. However, exhaustive design evaluations with kinetic models are computationally impractical, especially when targeting multiple enzymes. Here, we introduce a framework for efficiently scouting the design space while respecting cellular physiological requirements. The framework employs mixed-integer linear programming and nonlinear simulations with large-scale nonlinear kinetic models to devise genetic interventions while accounting for the network effects of these perturbations. Importantly, it ensures the engineered strain's robustness by maintaining its phenotype close to that of the reference strain. The framework, applied to improve the anthranilate production in E. coli, devises designs for experimental implementation, including eight previously experimentally validated targets. We expect this framework to play a crucial role in future design-build-test-learn cycles, significantly expediting the strain design compared to exhaustive design enumeration.

Indexed as

Escherichia coliGenetic EngineeringKineticsLearningPhenotype

Identifiers

PMID38267425
PMCPMC10808392
OpenAlexW4391164513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.